Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis.
Olaru ID, Heyckendorf J, Andres S, Kalsdorf B, Lange C. Olaru ID, et al. Among authors: andres s. Eur Respir J. 2017 May 21;49(5):1700742. doi: 10.1183/13993003.00742-2017. Print 2017 May. Eur Respir J. 2017. PMID: 28529207 Free article. No abstract available.
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Heyckendorf J, Andres S, Köser CU, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. Heyckendorf J, et al. Among authors: andres s. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01550-17. doi: 10.1128/AAC.01550-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133554 Free PMC article.
Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".
Köser CU, Heyckendorf J, Andres S, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. Köser CU, et al. Among authors: andres s. Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00616-18. doi: 10.1128/AAC.00616-18. Print 2018 Aug. Antimicrob Agents Chemother. 2018. PMID: 30054377 Free PMC article. No abstract available.
Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia.
Merker M, Barbier M, Cox H, Rasigade JP, Feuerriegel S, Kohl TA, Diel R, Borrell S, Gagneux S, Nikolayevskyy V, Andres S, Nübel U, Supply P, Wirth T, Niemann S. Merker M, et al. Among authors: andres s. Elife. 2018 Oct 30;7:e38200. doi: 10.7554/eLife.38200. Elife. 2018. PMID: 30373719 Free PMC article.
Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.
Andres S, Merker M, Heyckendorf J, Kalsdorf B, Rumetshofer R, Indra A, Hofmann-Thiel S, Hoffmann H, Lange C, Niemann S, Maurer FP. Andres S, et al. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1564-1568. doi: 10.1164/rccm.201909-1819LE. Am J Respir Crit Care Med. 2020. PMID: 32053752 No abstract available.
Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB.
Feuerriegel S, Kohl TA, Utpatel C, Andres S, Maurer FP, Heyckendorf J, Jouet A, Badalato N, Foray L, Fouad Kamara R, Conteh OS, Supply P, Niemann S. Feuerriegel S, et al. Among authors: andres s. Eur Respir J. 2021 Jan 5;57(1):2001796. doi: 10.1183/13993003.01796-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32764113 Free article. No abstract available.
MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era.
Beckert P, Sanchez-Padilla E, Merker M, Dreyer V, Kohl TA, Utpatel C, Köser CU, Barilar I, Ismail N, Omar SV, Klopper M, Warren RM, Hoffmann H, Maphalala G, Ardizzoni E, de Jong BC, Kerschberger B, Schramm B, Andres S, Kranzer K, Maurer FP, Bonnet M, Niemann S. Beckert P, et al. Among authors: andres s. Genome Med. 2020 Nov 25;12(1):104. doi: 10.1186/s13073-020-00793-8. Genome Med. 2020. PMID: 33239092 Free PMC article.
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing.
Grobbel HP, Merker M, Köhler N, Andres S, Hoffmann H, Heyckendorf J, Reimann M, Barilar I, Dreyer V, Hillemann D, Kalsdorf B, Kohl TA, Sanchez Carballo P, Schaub D, Todt K, Utpatel C, Maurer FP, Lange C, Niemann S. Grobbel HP, et al. Among authors: andres s. Clin Infect Dis. 2021 Oct 5;73(7):1194-1202. doi: 10.1093/cid/ciab359. Clin Infect Dis. 2021. PMID: 33900387 Free PMC article.
338 results